Pentedrone (also known as α-methylaminovalerophenone) is a stimulant of the cathinone class that has been sold as a designer drug and has been found since 2010 as an ingredient in a number of "bath salt" mixes sold as legal highs.[3][4][5][6][7][8][9]
Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.231.338 |
Chemical and physical data | |
Formula | C12H17NO |
Molar mass | 191.274 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |
Pentedrone acts as a norepinephrine-dopamine reuptake inhibitor without causing their release, the same mechanism of action as methylphenidate.[10][11]
Pentedrone has been linked to at least one death where it was combined with α-PVP and caused heart failure.[12]
A forensic standard of pentedrone is available, and the compound has been posted on the Forendex website of potential drugs of abuse.[13]
On January 28, 2014, the DEA listed it, along with nine other synthetic cathinones, on the Schedule 1 with a temporary ban, effective February 27, 2014.[14]
Pentedrone is an Anlage II controlled drug in Germany.
As of October 2015 Pentedrone is a controlled substance in China.[15]
Pentedrone is banned in the Czech Republic.[16]